FDA issues Final Rule on Residue-Tolerance Standards

The final rule does not establish new tolerances.
The final rule does not establish new tolerances.
(John Maday)

The FDA’s Center for Veterinary Medicine this week issued a final rule, “New Animal Drugs; Updating Tolerances for Residues of New Animal Drugs in Food.” The final rule standardizes and clarifies the standards for determining, codifying, and updating tolerances, and also provides a definition section of key terms that the FDA uses in the determination of tolerances.

With these revisions, the FDA intends to enhance understanding of tolerance determination and improve the overall readability of the relevant regulations. The rule does not establish new tolerances.

The FDA first proposed the rule in 2012, followed by a supplemental proposal in 2016, both with opportunities for public comment. The final rule will become effective 60 days from the date of publication in the Federal Register, scheduled for July 11, 2019.

According to the FDA, the action intends to more clearly explain current thinking about certain provisions of the 2012 document based on comments from stakeholders, and to more accurately reflect the rationale FDA relied on in the past to approve certain new animal drugs without a tolerance.

The 2012 proposed rule, according to the FDA document, did not adequately explain FDA’s current view that methods other than the “regulatory method” submitted by a sponsor as part of the new animal drug application can be used to determine the quantity of residue in edible tissues for surveillance and enforcement purposes. The new proposal would remove the definition for “regulatory method” and are reserve the term for use with carcinogenic compounds.

The rule also revises definitions for “marker residue,” “tolerance,” “not required,” “zero” and “acceptable single-dose intake,” and add a definition for “acute reference dose.”

View more details in the Federal Register.

For more on drug residues in food animal production, see these articles from BovineVetOnline:

Residues Becoming More Elusive

Updated Drug Residues Reference Guides Now Available in Spanish

Composting Manure Could Reduce Antibiotic Residues

 

 

Latest News

Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities
Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities

The Meat Institute said properly prepared beef remains safe to eat and called for USDA and the CDC to provide worker safety guidance specific to beef processors to ensure workers are protected from infection.

 A Message to the Ag Industry about H5N1
A Message to the Ag Industry about H5N1

The livestock industry needs a comprehensive, cohesive plan to address the virus. Producers, their employees and veterinarians need clear answers and support from U.S. agricultural leadership, moving forward.

USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread
USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread

USDA is now ordering all dairy cattle must be tested prior to interstate travel as a way to help stop the spread of HPAI H5N1. This comes a day after FDA confirmed virus genetic material was found in retail milk samples.

Mistrial Declared in Arizona Rancher’s Murder Trial
Mistrial Declared in Arizona Rancher’s Murder Trial

A lone juror stood between rancher George Kelly and innocent. “It is what it is, and it will be what it will be. Let me go home, okay?”

USDA Shares Recent H5N1 Avian Flu Sequences
USDA Shares Recent H5N1 Avian Flu Sequences

APHIS announced it has shared 239 genetic sequences of the H5N1 avian flu virus which will help scientists look for new clues about the spread of the virus.

Fairlife Breaks Ground on $650 Million Facility in New York
Fairlife Breaks Ground on $650 Million Facility in New York

Fairlife is known for its value-added dairy products, such as ultra-filtered milk, protein shakes and lactose-free milk. Soon, the company will be producing these popular products at its upcoming facility in N.Y.